A case for screening real-world data for collateral drug benefits: Glucagon-like peptide 1 receptor agonists and bile acid diarrhea.
在篩選實際世界數據中尋找藥物附帶益處的案例:GLP-1 受體激動劑與膽酸腹瀉。
Pharmacoepidemiol Drug Saf 2024-05-13
Emerging uses of glucagon-like peptide 1 (GLP-1) receptor agonists following ileal resection: literature review and case examples.
腸末端切除後胰高血糖素樣肽-1(GLP-1)受體激動劑的新興用途:文獻回顧與案例示例。
Frontline Gastroenterol 2023-10-20
Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea.
一周一次和每日一次給予GLP-1RA Semaglutide和Liraglutide對膽酸性腹瀉的不同影響。
JCEM Case Rep 2023-11-02
Evaluation of Alternative Treatment Strategies for Bile Acid Malabsorption in Inflammatory Bowel Disease Patients: A Network Meta-Analysis.
炎症性腸道疾病患者膽酸吸收不良的替代治療策略評估:網絡荟萃分析。
J Clin Med Res 2024-03-30
The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice.
GLP-1 受體激動劑 Liraglutide 獨立於進食降低小鼠結腸中的初級膽汁酸和血清素。
Int J Mol Sci 2024-07-27
Advances in the pathophysiology, diagnosis and management of chronic diarrhoea from bile acid malabsorption: a systematic review.
膽酸吸收不良引起的慢性腹瀉的病理生理、診斷和管理的進展:系統性回顧。
Eur J Intern Med 2024-07-28